Related Experiment Video
Updated: May 27, 2026
06:14
The Micronucleus Assay on Cryopreserved Whole Blood
Published on: February 23, 2024
Elevated micronuclei frequency in type 2 diabetes with high glycosylated hemoglobin
Suresh K G Shettigar1, C Shailaja, Ratnakar K Kulkarni
1Cytogenetics and Molecular Genetics Section, Pathology Unit, Medical Division, BARC Hospital, Anushaktinagar, Mumbai 400094, India. sureshs@barc.gov.in
Diabetes Research and Clinical Practice
|November 15, 2011
Summary
Type 2 diabetes patients show increased DNA damage, indicated by higher micronuclei frequency, linked to elevated glycosylated hemoglobin. This suggests a potential biomarker for future diabetic complications.
Area of Science:
- Biochemistry
- Genetics
- Endocrinology
Background:
- Hyperglycemia in type 2 diabetes is known to cause oxidative DNA damage.
- Glycosylation of proteins, including hemoglobin, increases with blood glucose levels.
Purpose of the Study:
- To evaluate the induction of micronuclei as a marker of DNA damage in type 2 diabetes patients.
- To investigate the relationship between increased glycosylation and micronuclei formation.
Main Methods:
- A study involving 49 participants, divided into normoglycemic controls and type 2 diabetes cases.
- Whole blood cultures were used to score micronuclei.
- Correlations were analyzed with age, sex, blood glucose, and glycosylated hemoglobin levels.
Main Results:
- Diabetic patients exhibited a significantly higher frequency of micronuclei compared to normoglycemic controls.
- Increased micronuclei frequency was correlated with elevated glycosylated hemoglobin levels (R(2)=0.229, p=0.037).
Conclusions:
- Elevated glycosylation in type 2 diabetes appears to induce oxidative DNA damage, evidenced by increased micronuclei frequency.
- Micronuclei frequency may serve as a potential biomarker for predicting diabetic complications.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...